Literature DB >> 3917677

Studies on interleukin 2 receptor expression and IL-2 production by murine T cell lymphomas.

T Diamantstein, H Osawa, L Graf, V Schirrmacher.   

Abstract

In order to study the possible role of the T-lymphocyte growth factor, Interleukin 2 (IL-2), and/or of the IL-2 receptor in the autonomous growth of leukaemic cells, 15 mouse leukaemic cell lines of various aetiology were analyzed for (i) IL-2 receptor expression and (ii) for the capacity to secrete IL-2. Several but not all of the cell lines tested were IL-2 receptor positive. The cells constitutively expressing IL-2 receptors at their surface could not be stimulated to secrete IL-2. Cell producing and secreting IL-2 did not express detectable amounts of IL-2 receptors at their surface. It has been demonstrated that proliferation of the leukaemic cells was independent of exogenous IL-2. The monoclonal anti-IL-2 receptor antibody AMT-13 inhibited IL-2 dependent proliferation of activated normal T-lymphocytes but failed to inhibit the growth of IL-2 receptor expressing leukaemic cells. The results argue against the autocrine stimulation hypothesis but do not exclude the possibility of involvement of functionally altered IL-2 receptors on autonomous cell growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917677      PMCID: PMC1976818          DOI: 10.1038/bjc.1985.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.

Authors:  K Bosslet; V Schirrmacher; G Shantz
Journal:  Int J Cancer       Date:  1979-09-15       Impact factor: 7.396

2.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

Authors:  V Schirrmacher; G Shantz; K Clauer; D Komitowski; H P Zimmermann; M L Lohmann-Matthes
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

Review 3.  Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis.

Authors:  R C Gallo; F Wong-Staal
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

4.  Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system.

Authors:  R Dzarlieva; V Schirrmacher; N F Fusenig
Journal:  Int J Cancer       Date:  1982-11-15       Impact factor: 7.396

Review 5.  The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses.

Authors:  J J Farrar; W R Benjamin; M L Hilfiker; M Howard; W L Farrar; J Fuller-Farrar
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  "Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells.

Authors:  J Reimann; T Diamantstein
Journal:  Immunobiology       Date:  1980-12       Impact factor: 3.144

7.  Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event?

Authors:  T Diamantstein; M Klos; J Reimann
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

8.  Suppression of T cell responses through competition for T cell growth factor (interleukin 2).

Authors:  J Günther; W Haas; H Von Boehmer
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

9.  Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

Authors:  T Hattori; T Uchiyama; T Toibana; K Takatsuki; H Uchino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

10.  Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes.

Authors:  K Bosslet; V Schirrmacher
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  4 in total

1.  The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.

Authors:  H D Volk; O Josimovic-Alasevic; M Gross; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Comparative analysis and anatomic distribution of ras p21, IL-2R, and MEL-14 in malignant and hyperplastic murine thymus.

Authors:  E W Newcomb; A Pellicer; C Cordon
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity.

Authors:  V Schirrmacher; O Josimovic-Alasevic; H Osawa; T Diamantstein
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.